Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Incidence of adverse reactions to azathioprine in patients with Crohn's disease

Nature Clinical Practice Gastroenterology & Hepatology volume 2, pages 510–511 (2005)Cite this article

boxed-textBajaj JS et al. (2005) Incidence of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience. Am J Gastroenterol 100: 1121–1125

Although the benefits of azathioprine therapy clearly outweigh the risks, patients with Crohn's disease are at higher risk of adverse events and this should be discussed with them before therapy

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Weersma RK et al. (2005) Increased incidence of azathioprine induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 20: 843–850

    Article  Google Scholar 

  2. Pearson DC et al. (1995) Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 123: 132–142

    Article  CAS  Google Scholar 

  3. Present DH et al. (1989) 6-mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 111: 641–649

    Article  CAS  Google Scholar 

  4. Marinaki AM et al. (2004) Mutation in the ITPA gene predicts intolerance to azathioprine. Nucleosides Nucleotides Nucleic Acids 23: 1393–1397

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Gastroenterologist and Head of Gastroenterology and Endoscopy at Guy's & St Thomas' Hospital, London, UK

    Jeremy Sanderson

Authors
  1. Jeremy Sanderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanderson, J. Incidence of adverse reactions to azathioprine in patients with Crohn's disease. Nat Rev Gastroenterol Hepatol 2, 510–511 (2005). https://doi.org/10.1038/ncpgasthep0314

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0314

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing